The Shanghai Composite Index edged down 0.1% to close at 4,051, while the Shenzhen Component Index rose 0.6% to 14,885 on Friday, with mainland equities trading mixed as investors awaited clearer signals on whether the weeks-long conflict in Iran could ease ahead of potential weekend talks. Still, both benchmarks ended the week on a firm note, with the Shanghai up 1.6% and the Shenzhen gaining 4%, as sentiment was cautiously underpinned by a 10-day Lebanon–Israel ceasefire and remarks from Trump pointing to a possible US–Iran meeting over the weekend, bolstering hopes of de-escalation. In China, focus shifts to policy, with the loan prime rate decision due Monday. Major global banks have pared back expectations for further easing, now expecting rates to remain steady through the year. Among individual stocks, liquor maker Kweichow Moutai led losses, falling 3.8% on weaker annual results, while Zhongji Innolight climbed 5.1% to a record high after reporting strong first-quarter profits.
China's main stock market index, the SHANGHAI, fell to 4051 points on April 17, 2026, losing 0.10% from the previous session. Over the past month, the index has declined 0.28%, though it remains 23.64% higher than a year ago, according to trading on a contract for difference (CFD) that tracks this benchmark index from China. Historically, the China Shanghai Composite Stock Market Index reached an all time high of 6124.04 in October of 2007. China Shanghai Composite Stock Market Index - data, forecasts, historical chart - was last updated on April 18 of 2026.
China's main stock market index, the SHANGHAI, fell to 4051 points on April 17, 2026, losing 0.10% from the previous session. Over the past month, the index has declined 0.28%, though it remains 23.64% higher than a year ago, according to trading on a contract for difference (CFD) that tracks this benchmark index from China. The China Shanghai Composite Stock Market Index is expected to trade at 3915.71 points by the end of this quarter, according to Trading Economics global macro models and analysts expectations. Looking forward, we estimate it to trade at 3678.09 in 12 months time.